| Status |
Title |
Age |
Phase |
| Active, not recruiting |
A Study of Chemo Chemoresponse Assay in Solid Tumors - Chemo Registry Study |
Adult|Senior |
|
| Active, not recruiting |
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase III |
| Active, not recruiting |
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation |
Adult|Senior |
Phase III |
| Active, not recruiting |
AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery |
Adult|Senior |
Phase II |
| Active, not recruiting |
AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery |
Adult|Senior |
Phase II |
| Active, not recruiting |
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 |
Adult|Senior |
|
| Active, not recruiting |
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Capecitabine in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM |
Adult|Senior |
Phase I|Phase II |
| Active, not recruiting |
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura |
Adult|Senior |
Phase III |
| Active, not recruiting |
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma |
Adult|Senior |
Phase I |
| Active, not recruiting |
Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung |
Adult|Senior |
Phase II |
| Active, not recruiting |
Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma |
Child|Adult|Senior |
Phase II |
| Active, not recruiting |
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery |
Adult|Senior |
|
| Active, not recruiting |
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer |
Child|Adult |
Phase I |
| Active, not recruiting |
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Eloxatin Plus Gemcitabine Chemotherapy for Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate |
Adult|Senior |
Phase II |
| Active, not recruiting |
Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery |
Adult|Senior |
Phase II |
| Active, not recruiting |
Gene Therapy for Pleural Malignancies |
Adult|Senior |
Phase I |
| Active, not recruiting |
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma |
Adult|Senior |
Phase I|Phase II |
| Active, not recruiting |
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions |
Adult|Senior |
Phase I |
| Active, not recruiting |
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Molecular Predictors of Pemetrexed and Carboplatin Response in Tumor Samples of a Series of Malignant Pleural Mesothelioma (MPM) Patients and Genotyping for the TSER Polymorphism |
Adult|Senior |
|
| Active, not recruiting |
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen |
Adult|Senior |
Phase III |
| Active, not recruiting |
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma |
Child|Adult|Senior |
Phase II |
| Active, not recruiting |
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Pazopanib in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma |
Child|Adult|Senior |
Phase II |
| Active, not recruiting |
Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery |
Adult|Senior |
Phase II |
| Active, not recruiting |
Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma |
Adult|Senior |
Phase I |
| Active, not recruiting |
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer |
Adult|Senior |
|
| Active, not recruiting |
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma |
Child|Adult|Senior |
Phase III |
| Active, not recruiting |
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer |
Child|Adult|Senior |
Phase II |
| Active, not recruiting |
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed |
Adult|Senior |
Phase II |
| Active, not recruiting |
Rapamycin With Grapefruit Juice for Advanced Malignancies |
Adult|Senior |
Phase I |
| Active, not recruiting |
Response Evaluation in Malignant Pleural Mesothelioma |
Adult|Senior |
|
| Active, not recruiting |
Sorafenib in Previously Treated Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Sorafenib in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Active, not recruiting |
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer |
Adult|Senior |
Phase II |
| Active, not recruiting |
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma |
Child|Adult|Senior |
Phase I |
| Active, not recruiting |
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer |
Adult|Senior |
Phase II |
| Approved for marketing |
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma. |
Adult|Senior |
Phase II |
| Completed |
A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma |
Adult|Senior |
Phase III |
| Completed |
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer |
Adult|Senior |
Phase I |
| Completed |
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors |
Adult|Senior |
Phase I |
| Completed |
Alanosine in Treating Patients With Cancer |
Child|Adult|Senior |
Phase II |
| Completed |
An Open-Label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery |
Adult|Senior |
Phase III |
| Completed |
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase I |
| Completed |
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors |
Child|Adult |
Phase II |
| Completed |
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer |
Adult|Senior |
Phase II |
| Completed |
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura |
Adult|Senior |
Phase I |
| Completed |
Dendritic Cell-based Immunotherapy in Mesothelioma |
Adult|Senior |
Phase I |
| Completed |
Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer |
Adult|Senior |
|
| Completed |
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung |
Child|Adult|Senior |
Phase II |
| Completed |
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction |
Adult|Senior |
Phase I |
| Completed |
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain |
Adult|Senior |
Phase III |
| Completed |
Gefitinib in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment |
Adult|Senior |
Phase II |
| Completed |
Immunotoxin Therapy in Treating Patients With Advanced Cancer |
Adult|Senior |
Phase I |
| Completed |
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors |
Adult|Senior |
Phase I |
| Completed |
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs |
Adult|Senior |
Phase I |
| Completed |
Interleukin-12 in Treating Patients With Cancer in the Abdomen |
Adult|Senior |
Phase I |
| Completed |
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma |
Adult|Senior |
Phase I |
| Completed |
Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma |
Adult|Senior |
Phase I |
| Completed |
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies |
Adult|Senior |
Phase I |
| Completed |
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors |
Adult|Senior |
Phase I |
| Completed |
Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases |
Child|Adult|Senior |
Phase II |
| Completed |
Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer |
Adult|Senior |
Phase I |
| Completed |
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery |
Adult|Senior |
Phase II |
| Completed |
Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy |
Adult|Senior |
|
| Completed |
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. |
Adult|Senior |
Phase I |
| Completed |
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors |
Adult|Senior |
Phase I |
| Completed |
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer |
Adult|Senior |
Phase II |
| Completed |
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen |
Adult|Senior |
Phase II |
| Completed |
Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase I|Phase II |
| Completed |
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors |
Adult|Senior |
Phase I |
| Completed |
SU5416 in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Completed |
Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors |
Adult, Senior |
Phase I |
| Completed |
Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy |
Adult|Senior |
Phase I |
| Completed |
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy |
Child|Adult |
Phase II |
| Completed |
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma |
Adult|Senior |
Phase I |
| Completed |
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma |
Adult|Senior |
Phase I |
| Enrolling by invitation |
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial |
Adult|Senior |
|
| Not yet recruiting |
A Phase II Study of the Association of Glivec Plus Gemzar in Patients With Unresectable, Refractory, Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Not yet recruiting |
A Study in Non Small Cell Lung Cancer |
Adult|Senior |
Phase I|Phase II |
| Not yet recruiting |
AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
1-Methyl-d-Tryptophan in Treating Patients With Relapsed or Refractory Solid Tumors |
Adult/Senior |
Phase I |
| Recruiting |
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. |
Adult|Senior |
Phase II |
| Recruiting |
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma |
Adult/Senior |
Phase II |
| Recruiting |
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
Axitinib in Malignant Mesothelioma |
Adult|Senior |
Phase I|Phase II |
| Recruiting |
B-Receptor Signaling in Cardiomyopathy |
Child|Adult |
|
| Recruiting |
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite |
Adult|Senior |
|
| Recruiting |
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
ChemoFx PRO - A Post-Market Data Collection Study |
Adult|Senior |
|
| Recruiting |
Collecting Tumor Samples From Patients With Gynecological Tumors |
Child|Adult|Senior |
|
| Recruiting |
Combination Gene Transfer and Chemotherapy |
Adult|Senior |
Phase 0 |
| Recruiting |
Dasatinib in Resectable Malignant Pleural Mesothelioma |
Adult|Senior |
Phase I |
| Recruiting |
Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases |
Adult/Senior |
Phase I |
| Recruiting |
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma |
Child|Adult|Senior |
Phase I |
| Recruiting |
Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers |
Adult|Senior |
|
| Recruiting |
Electronic Tool to Record Cancer Symptoms in Patients With Advanced Cancer Receiving Palliative Care |
Adult|Senior |
Phase III |
| Recruiting |
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity |
Adult|Senior |
Phase II |
| Recruiting |
Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery |
Adult|Senior |
Phase II |
| Recruiting |
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma |
Adult|Senior |
Phase I |
| Recruiting |
FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer |
Adult|Senior |
Phase I |
| Recruiting |
Identification of Key Blood Molecular Markers for Immunotherapy |
Adult|Senior |
|
| Recruiting |
Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery |
Adult|Senior |
Phase I |
| Recruiting |
Intrapleural Gene Transfer for Pleural Mesothelioma |
Adult|Senior |
Phase I |
| Recruiting |
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia |
Child|Adult|Senior |
|
| Recruiting |
Mesothelioma Avastin Plus Pemetrexed-cisplatin Study |
Adult|Senior |
Phase II|Phase III |
| Recruiting |
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy |
Adult|Senior |
|
| Recruiting |
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed |
Adult|Senior |
Phase III |
| Recruiting |
Optical Coherence Tomography of the Airway in Detecting Abnormal Cells in Patients Undergoing Surgery for Lung Cancer or Lung Disease |
Child|Adult|Senior |
Phase I |
| Recruiting |
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma |
Adult|Senior |
Phase I|Phase II |
| Recruiting |
Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy |
Adult|Senior |
Phase II |
| Recruiting |
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide |
Adult|Senior |
Phase I |
| Recruiting |
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy |
Adult|Senior |
Phase II |
| Recruiting |
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas |
Adult|Senior |
Phase I|Phase II |
| Recruiting |
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) |
Adult|Senior |
Phase II |
| Recruiting |
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate |
Adult|Senior |
Phase II |
| Recruiting |
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer |
Adult|Senior |
|
| Recruiting |
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) |
Child|Adult|Senior |
|
| Recruiting |
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) |
Adult|Senior |
Phase I |
| Recruiting |
Randomized Study of Adjuvant WT-1 Analog Peptide Vaccine in Patients With Malignant Pleural Mesothelioma (MPM) After Completion of Combined Modality Therapy |
Adult|Senior |
Phase II |
| Recruiting |
Short Neoadjuvant Hemithoracic IMRT for MPM |
Adult|Senior |
Phase I|Phase II |
| Recruiting |
Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II) |
Adult|Senior |
Phase I|Phase II |
| Recruiting |
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma |
Adult|Senior |
Phase I |
| Recruiting |
Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Mediastinal or Chest Wall Neoplasms, or Lung Metastases From Cancers of Non-Thoracic Origin |
Child|Adult|Senior |
|
| Recruiting |
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy |
Adult|Senior |
Phase II |
| Recruiting |
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1) |
Adult|Senior |
Phase III |
| Recruiting |
Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis |
Adult|Senior |
Phase II |
| Recruiting |
Tomotherapy Treatment for Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) |
Adult|Senior |
Phase II |
| Recruiting |
Tumor Cell Vaccines With ISCOMATRIX(Trademark) Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas |
Adult|Senior |
Phase I |
| Recruiting |
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma |
Adult|Senior |
Phase II |
| Recruiting |
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma |
Adult|Senior |
Phase III |
| Suspended |
Flavopiridol in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies |
Adult|Senior |
Phase I |
| Suspended |
Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer |
Adult|Senior |
Phase I|Phase II |
| Terminated |
An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma |
Adult|Senior |
Phase II |
| Terminated |
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma |
Child|Adult|Senior |
Phase II |
| Terminated |
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) |
Adult|Senior |
Phase IV |
| Terminated |
Study of Pemetrexed for Second-Line Pancreas Cancer |
Adult|Senior |
Phase II |
| Terminated |
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment |
Adult|Senior |
Phase I |
| Terminated |
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days |
Adult|Senior |
Phase I |
| Terminated |
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses |
Adult|Senior |
Phase I |
| Withdrawn |
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma |
Adult|Senior |
Phase I|Phase II |
| Withdrawn |
CryoSpray Ablation(tm)Thoracic Patient Registry |
Adult|Senior |
|
| Withdrawn |
Ixabepilone and Pemetrexed/Solid Tumors |
Adult|Senior |
Phase I |
